Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease

BACKGROUND: The role of intestinal microbiota in inflammatory bowel diseases is intensively researched. Pediatric studies on the relation between microbiota and treatment response are sparse. We aimed to determine whether absolute abundances of gut microbes characterize the response to infliximab in...

Descripción completa

Detalles Bibliográficos
Autores principales: Höyhtyä, Miikka, Korpela, Katri, Saqib, Schahzad, Junkkari, Sofia, Nissilä, Eija, Nikkonen, Anne, Dikareva, Evgenia, Salonen, Anne, de Vos, Willem M, Kolho, Kaija-Leena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic Science Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825283/
https://www.ncbi.nlm.nih.gov/pubmed/36040412
http://dx.doi.org/10.1093/ibd/izac182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825283/
https://www.ncbi.nlm.nih.gov/pubmed/36040412
http://dx.doi.org/10.1093/ibd/izac182

Ejemplares similares